ADAG logo

Adagene (ADAG)

Profile

Full Name

Adagene Inc.

Ticker Symbol

ADAG

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

China

IPO

February 9, 2021

Indexes

Not included

Website

http://www.adagene.com

Employees

138

Key Details

Price

$1.52(-0.65%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$103.20K(-99.43% YoY)

Annual EPS

-$0.74(-68.57% YoY)

PE ratio

-

Next earnings date

Jul 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.52
ADAG price is $1.52

30-Day Relative Volume

0.26
ADAG 30-day relative volume is 0.26

Price Performance

Price Most recent change

-0.65%
ADAG price was down -0.65% on Apr 14, 2025

Price YTD change

-23.62%
ADAG price is down -23.62% since January 1st

Price 1-year change

-41.54%
ADAG price is down -41.54% year-on-year

Price 3-year change

-59.03%
ADAG price is down -59.03% over the past 3 years

Price Range

Price All-time high

$31.83
ADAG price is currently -95.22% below its historical high of $31.83

Price 3-year low

$0.90
ADAG price is currently +68.89% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$71.61M
ADAG market capitalization is $71.61 million

Market cap 3-year change

-55.93%
ADAG market capitalization is down -55.93% over the past 3 years

Market cap All-time high

$1.26B
ADAG market capitalization is currently -94.34% below its historical high of $1.26 billion

Market cap sector rank

43.59%
ADAG market capitalization is higher than 43.59% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+6.69%
ADAG shares outstanding is up +6.69% year-on-year

Shares Outstanding 3-Year Change

+7.57%
ADAG shares outstanding is up +7.57% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.16
ADAG beta is 0.16

200-day SMA

$2.27
ADAG price is currently -33.07% below its 200-day simple moving average

50-day SMA

$1.80
ADAG price is currently -15.59% below its 50-day simple moving average

RSI

41.54
ADAG 14-day relative strength index is 41.54

Volume

0.26
ADAG 30-day relative volume is 0.26

ATR

$0.13
ADAG average true range is $0.13

10-day Historical Volatility

127.33%
ADAG 10-day historical volatility is 127.33%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$103.20K
ADAG annual revenue is $103.20 thousand

Revenue Analysts estimate

-
ADAG annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-99.43%
ADAG annual revenue is down -99.43% year-on-year

Revenue Sector rank

5.15%
ADAG annual revenue is higher than 5.15% of companies in Healthcare sector

EPS

EPS

-$0.74
ADAG annual earnings per share is -$0.74

EPS Analysts estimate

-$0.83
ADAG annual earnings per share is currently -11.14% lower than the consensus analysts' forecast

EPS 1-year change

-68.57%
ADAG annual earnings per share is down -68.57% year-on-year

EPS Sector rank

62.45%
ADAG annual earnings per share is higher than 62.45% of companies in Healthcare sector

Profit

Gross profit

-
ADAG annual gross profit value is unknown

Gross margin

-
ADAG annual gross profit margin value is unknown

Operating profit

-$35.95M
ADAG annual operating income is -$35.95 million

Operating margin

-34.84K%
ADAG annual operating profit margin is -34.84 thousand%

Net income

-$33.42M
ADAG annual net profit is -$33.42 million

Net margin

-32.39K%
ADAG annual net profit margin is -32.39 thousand%

Expenses

Total expenses

$36.05M
ADAG annual total expenses is $36.05 million

Operating expenses

$36.05M
ADAG annual total operating expenses is $36.05 million

Cost of goods sold

-
ADAG annual cost of goods sold value is unknown

Selling, general & administrative expenses

$7.27M
ADAG annual SGA is $7.27 million

Depreciation and amortization

$938.90K
ADAG annual depreciation & amortization is $938.90 thousand

Interest expense

$851.90K
ADAG annual interest expense is $851.90 thousand

Income tax

-$17.60K
ADAG annual income tax is -$17.60 thousand

EBIT & EBITDA

EBIT

-$32.59M
ADAG annual earnings before interest & taxes is -$32.59 million

EBITDA

-$31.65M
ADAG annual EBITDA is -$31.65 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$89.27M
ADAG annual total assets is $89.27 million

Non current assets

$1.49M
ADAG annual long term assets is $1.49 million

Current assets

$87.78M
ADAG annual total current assets is $87.78 million

Cash and cash equivalents

$85.19M
ADAG annual cash & cash equivalents is $85.19 million

Accounts receivable

-
ADAG annual accounts receivable value is unknown

Inventory

-
ADAG annual inventory value is unknown

Liabilities

Total liabilities

$38.74M
ADAG annual total liabilities is $38.74 million

Long term liabilities

$559.60K
ADAG annual total long term liabilities is $559.60 thousand

Current liabilities

$38.18M
ADAG annual total current liabilities is $38.18 million

Accounts payable

$4.24M
ADAG annual accounts payable is $4.24 million

Debt

Total debt

$18.49M
ADAG annual total debt is $18.49 million

Total debt 1-year change

-17.1%
ADAG annual total debt is down -17.1% year-on-year

Long term debt

$559.60K
ADAG annual long term debt is $559.60 thousand

Short term debt

$17.93M
ADAG annual short term debt is $17.93 million

Equity & Capital

Shareholders equity

$50.52M
ADAG annual stockholders equity is $50.52 million

Book value

$50.52M
ADAG annual book value is $50.52 million

Retained earnings

-$311.18M
ADAG annual retained earnings is -$311.18 million

Working capital

$49.59M
ADAG annual working capital is $49.59 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$29.70M
ADAG annual cash flow from operations is -$29.70 million

Cash from operations 1-year change

-4.38%
ADAG annual cash flow from operations is down -4.38% year-on-year

Cash from investing

$1.11M
ADAG annual cash flow from investing activities is $1.11 million

Cash from investing 1-year change

+1534.24%
ADAG annual cash flow from investing activities is up +1534.24% year-on-year

Cash from financing

$3.77M
ADAG annual cash flow from financing activities is $3.77 million

Cash from financing 1-year change

+170.23%
ADAG annual cash flow from financing activities is up +170.23% year-on-year

CAPEX

CAPEX

$33.60K
ADAG annual capital expenditures is $33.60 thousand

CAPEX 1-year change

-60.47%
ADAG annual capital expenditures is down -60.47% year-on-year

Free Cash Flow

Free cash flow

-$29.73M
ADAG annual free cash flow is -$29.73 million

Free cash flow 1-year change

-4.19%
ADAG annual free cash flow is down -4.19% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ADAG annual gross profit margin value is unknown

Operating margin

-34.84K%
ADAG annual operating profit margin is -34.84 thousand%

Net margin

-32.39K%
ADAG annual net profit margin is -32.39 thousand%

ROA & ROE

ROA

-32.61%
ADAG annual return on assets is -32.61%

ROE

-55.21%
ADAG annual return on equity is -55.21%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ADAG price to earnings ratio value is unknown

PE ratio Sector rank

-
ADAG price to earnings ratio is unknown

PB Ratio

PB ratio

1.42
ADAG price to book ratio is 1.42

PB ratio Sector rank

53.33%
ADAG price to book ratio is higher than 53.33% of companies in Healthcare sector

PS Ratio

PS ratio

-
ADAG price to sales ratio value is unknown

PS ratio Sector rank

-
ADAG price to sales ratio is unknown

Enterprise value

Enterprise value

$4.91M
ADAG enterprise value is $4.91 million

Enterprise value Sector rank

19.34%
ADAG enterprise value is higher than 19.34% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
ADAG EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
ADAG EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.30
ADAG annual current ratio is 2.30

Quick ratio

-
ADAG annual quick ratio value is unknown

Leverage

Debt to equity

0.36
ADAG annual debt to equity ratio is 0.36

Interest coverage ratio

-38.26
ADAG annual interest coverage ratio is -38.26

Risk & Stability

Piotroski F-Score

-
ADAG piotroski f-score value is unknown

Altman Z-Score

-4.31
ADAG altman z-score is -4.31

Analyst ratings

Recent major analysts updates

Apr 3, 25 HC Wainwright & Co.
Buy
Jan 27, 25 HC Wainwright & Co.
Buy
Sep 18, 24 HC Wainwright & Co.
Buy
Jul 22, 24 HC Wainwright & Co.
Buy
Jun 28, 24 HC Wainwright & Co.
Buy
Oct 4, 23 HC Wainwright & Co.
Buy
Sep 1, 23 HC Wainwright & Co.
Buy
Apr 21, 23 HC Wainwright & Co.
Buy
Mar 29, 23 HC Wainwright & Co.
Buy
Mar 21, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

ADVM logo
Adverum Biotechnologies (ADVM)
IGMS logo
IGM Biosciences (IGMS)
Lexeo Therapeutics (LXEO)
CRBP logo
Corbus Pharmaceuticals Holdings (CRBP)
MLSS logo
Milestone Scientific (MLSS)
ZYXI logo
Zynex (ZYXI)
UNCY logo
Unicycive Therapeutics (UNCY)
TCRX logo
TScan Therapeutics (TCRX)
EPIX logo
ESSA Pharma (EPIX)
  • What is the ticker symbol for Adagene?
  • Does Adagene pay dividends?
  • What sector is Adagene in?
  • What industry is Adagene in?
  • What country is Adagene based in?
  • When did Adagene go public?
  • Is Adagene in the S&P 500?
  • Is Adagene in the NASDAQ 100?
  • Is Adagene in the Dow Jones?
  • When was Adagene's last earnings report?
  • When does Adagene report earnings?
  • Should I buy Adagene stock now?

What is the ticker symbol for Adagene?

The ticker symbol for Adagene is NASDAQ:ADAG

Does Adagene pay dividends?

No, Adagene does not pay dividends

What sector is Adagene in?

Adagene is in the Healthcare sector

What industry is Adagene in?

Adagene is in the Biotechnology industry

What country is Adagene based in?

Adagene is headquartered in China

When did Adagene go public?

Adagene's initial public offering (IPO) was on February 9, 2021

Is Adagene in the S&P 500?

No, Adagene is not included in the S&P 500 index

Is Adagene in the NASDAQ 100?

No, Adagene is not included in the NASDAQ 100 index

Is Adagene in the Dow Jones?

No, Adagene is not included in the Dow Jones index

When was Adagene's last earnings report?

Adagene's most recent earnings report was on Mar 24, 2025

When does Adagene report earnings?

The next expected earnings date for Adagene is Jul 25, 2025

Should I buy Adagene stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page